VEGFA and neoplasm: We also indicate that ANGPTL2 promotes VEGF-A-dependent lymphangiogenesis via integrin α5β1, p38 MAP kinase (MAPK) and NF-κB signaling, indicating that ANGPTL2 may be worth targeting when applying tumor-associated lymphangiogenesis.